Literature DB >> 22875896

Clonal distribution of common pneumococcal serotypes not included in the 7-valent conjugate vaccine (PCV7): marked differences between two ethnic populations in southern Israel.

Nurith Porat1, Rachel Benisty, Ronit Trefler, Noga Givon-Lavi, Ron Dagan.   

Abstract

This study aimed to compare the clonal distribution of common pneumococcal strains not included in the 7-valent pneumococcal conjugate vaccine (PCV7) that were isolated from cases of acute otitis media (AOM) and invasive pneumococcal disease (IPD) in two distinct ethnic populations in southern Israel during the decade (1999 to 2008) preceding PCV7 implementation. Isolates recovered from Jewish and Bedouin children <5 years old were characterized by antibiotic resistance and molecular epidemiology using pulsed-field gel electrophoresis and multilocus sequence typing. Of 5,236 AOM and 425 IPD isolates, 43% and 57% were from Jewish and Bedouin children, respectively. PCV7 accounted for 54% and 45% of the AOM and IPD episodes, respectively. Eleven major non-PCV7 serotypes (1, 3, 5, 6A, 7F, 12F, 15B/C, 19A, 21, 33F, and 35B) constituted 31% and 42% of the AOM and IPD episodes, respectively. The clonal distributions of the 11 non-PCV7 serotypes and their antibiotic susceptibilities were significantly different among the two ethnic populations in both the AOM and IPD groups. About half of the AOM and IPD cases resulted from non-PCV7 pneumococci, even before PCV7 implementation. The significant differences between the two ethnic populations suggest that lifestyle and microenvironment are major determinants in the clonal distribution of disease-causing pneumococci. Post-PCV7 surveillance is important in understanding non-PCV7 clonal expansion in the two distinct populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22875896      PMCID: PMC3486215          DOI: 10.1128/JCM.01309-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Differential circulation of Streptococcus pneumoniae serotype 6C clones in two Israeli pediatric populations.

Authors:  Nurith Porat; In Ho Park; Moon H Nahm; Ron Dagan
Journal:  J Clin Microbiol       Date:  2010-10-13       Impact factor: 5.948

2.  The changing epidemiology of invasive pneumococcal disease in aboriginal and non-aboriginal western Australians from 1997 through 2007 and emergence of nonvaccine serotypes.

Authors:  Deborah Lehmann; Judith Willis; Hannah C Moore; Carolien Giele; Denise Murphy; Anthony D Keil; Catherine Harrison; Kathy Bayley; Michael Watson; Peter Richmond
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

3.  The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement.

Authors:  Merit Melin; Krzysztof Trzciński; Seppo Meri; Helena Käyhty; Merja Väkeväinen
Journal:  Infect Immun       Date:  2010-09-20       Impact factor: 3.441

4.  Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

Authors:  Tamara Pilishvili; Catherine Lexau; Monica M Farley; James Hadler; Lee H Harrison; Nancy M Bennett; Arthur Reingold; Ann Thomas; William Schaffner; Allen S Craig; Philip J Smith; Bernard W Beall; Cynthia G Whitney; Matthew R Moore
Journal:  J Infect Dis       Date:  2010-01-01       Impact factor: 5.226

5.  Increasing importance of multidrug-resistant serotype 6A Streptococcus pneumoniae clones in acute otitis media in southern Israel.

Authors:  Nurith Porat; Uri Amit; Noga Givon-Lavi; Eugene Leibovitz; Ron Dagan
Journal:  Pediatr Infect Dis J       Date:  2010-02       Impact factor: 2.129

6.  Invasive pneumococcal disease in Indigenous people in north Queensland: an update, 2005-2007.

Authors:  Jeffrey N Hanna; Jan L Humphreys; Denise M Murphy
Journal:  Med J Aust       Date:  2008-07-07       Impact factor: 7.738

7.  Serotype replacement in perspective.

Authors:  Ron Dagan
Journal:  Vaccine       Date:  2009-06-21       Impact factor: 3.641

8.  New insights on pneumococcal disease: what we have learned over the past decade.

Authors:  Ron Dagan
Journal:  Vaccine       Date:  2009-06-23       Impact factor: 3.641

9.  Control of Streptococcus pneumoniae serotype 5 epidemic of severe pneumonia among young army recruits by mass antibiotic treatment and vaccination.

Authors:  Ran D Balicer; Salman Zarka; Hagai Levine; Eyal Klement; Tamar Sela; Nurith Porat; Nachman Ash; Ron Dagan
Journal:  Vaccine       Date:  2010-08-02       Impact factor: 3.641

10.  Pediatric parapneumonic empyema, Spain.

Authors:  Ignacio Obando; Carmen Muñoz-Almagro; Luis A Arroyo; David Tarrago; David Sanchez-Tatay; David Moreno-Perez; Sahar S Dhillon; Cristina Esteva; Susanna Hernandez-Bou; Juan J Garcia-Garcia; William P Hausdorff; Angela B Brueggemann
Journal:  Emerg Infect Dis       Date:  2008-09       Impact factor: 6.883

View more
  6 in total

Review 1.  What is Known About Health and Morbidity in the Pediatric Population of Muslim Bedouins in Southern Israel: A Descriptive Review of the Literature from the Past Two Decades.

Authors:  Yulia Treister-Goltzman; Roni Peleg
Journal:  J Immigr Minor Health       Date:  2015-06

2.  Baseline epidemiology and genetic structure of Streptococcus pneumoniae serotype 6D in southern Israel prior to introduction of pneumococcal conjugate vaccines.

Authors:  Nurith Porat; Rachel Benisty; Ronit Trefler; Doreen Ozalvo; Noga Givon-Lavi; Ron Dagan
Journal:  J Clin Microbiol       Date:  2013-02-27       Impact factor: 5.948

3.  Serotype 5 pneumococci causing invasive pneumococcal disease outbreaks in Barcelona, Spain (1997 to 2011).

Authors:  Dora Rolo; Asunción Fenoll; Dionísia Fontanals; Nieves Larrosa; Montserrat Giménez; Immaculada Grau; Román Pallarés; Josefina Liñares; Carmen Ardanuy
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

4.  Use of Pneumococcal Disease Epidemiology to Set Policy and Prevent Disease during 20 Years of the Emerging Infections Program.

Authors:  Matthew R Moore; Cynthia G Whitney
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

5.  Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel.

Authors:  Assaf Rokney; Shalom Ben-Shimol; Zinaida Korenman; Nurith Porat; Zeev Gorodnitzky; Noga Givon-Lavi; Merav Ron; Vered Agmon; Ron Dagan; Lea Valinsky
Journal:  Emerg Infect Dis       Date:  2018-03       Impact factor: 6.883

6.  Molecular epidemiology of serotype 19A Streptococcus pneumoniae among invasive isolates from Alaska, 1986-2010.

Authors:  Karen Rudolph; M G Bruce; L Bulkow; T Zulz; A Reasonover; M Harker-Jones; D Hurlburt; T W Hennessy
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.